- $2.18bn
- $2.36bn
- $1.69bn
- 97
- 50
- 46
- 69
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,119 | 1,163 | 1,334 | 1,514 | 1,690 |
Cost of Revenue | |||||
Gross Profit | 273 | 294 | 335 | 377 | 454 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 1,024 | 1,069 | 1,217 | 1,365 | 1,492 |
Operating Profit | 94.9 | 94.8 | 117 | 149 | 198 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 84.6 | 79.8 | 109 | 134 | 175 |
Provision for Income Taxes | |||||
Net Income After Taxes | 63.1 | 57.8 | 80.2 | 102 | 136 |
Net Income Before Extraordinary Items | |||||
Net Income | 63.1 | 57.8 | 80.2 | 102 | 136 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 63.1 | 57.8 | 80.2 | 102 | 136 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.35 | 4.88 | 6.75 | 8.54 | 11.4 |
Dividends per Share |